These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2577460)

  • 61. [Pharmacology of beta blockers and their significance for therapy of hypertension].
    Wehling M
    Herz; 2002 Aug; 27 Suppl 1():16-25. PubMed ID: 12229254
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.
    Collins R; Peto R; MacMahon S; Hebert P; Fiebach NH; Eberlein KA; Godwin J; Qizilbash N; Taylor JO; Hennekens CH
    Lancet; 1990 Apr; 335(8693):827-38. PubMed ID: 1969567
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Results of MRC (UK) trial of drug therapy for mild hypertension.
    Peart S
    Clin Invest Med; 1987 Nov; 10(6):616-20. PubMed ID: 3326701
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.
    Wikstrand J; Warnold I; Olsson G; Tuomilehto J; Elmfeldt D; Berglund G
    JAMA; 1988 Apr; 259(13):1976-82. PubMed ID: 3346979
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
    Matsuzaki M; Ogihara T; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Abe K; Suzuki N; Eto T; Higaki J; Ito S; Kamiya A; Kikuchi K; Suzuki H; Tei C; Ohashi Y; Saruta T;
    J Hypertens; 2011 Aug; 29(8):1649-59. PubMed ID: 21610513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atenolol and three nonselective beta-blockers in hypertension.
    Waal-Manning HJ
    Clin Pharmacol Ther; 1979 Jan; 25(1):8-18. PubMed ID: 31259
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New approaches to the uses of beta blocking drugs in hypertension.
    Prichard BN; Graham BR; Cruickshank JM
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S63-8. PubMed ID: 10854083
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Single-agent and combination therapy of essential hypertension.
    Weber MA; Drayer JI
    Am Heart J; 1984 Aug; 108(2):311-6. PubMed ID: 6147077
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Potential benefit of combination therapy with diuretics and beta blockers having intrinsic sympathomimetic activity.
    Weinberger MH
    Eur Heart J; 1990 Jun; 11(6):560-5. PubMed ID: 1972064
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
    Esler M; Kjeldsen SE; Pathak A; Grassi G; Kreutz R; Mancia G
    Blood Press; 2022 Dec; 31(1):210-224. PubMed ID: 36029011
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Initial therapy for mild hypertension.
    Wikstrand J
    Pharmacotherapy; 1986; 6(2):64-72. PubMed ID: 2872658
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diuretics in long-term treatment of hypertension: a comparison to beta-blockers.
    Berglund G
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S256-9. PubMed ID: 6204151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.